What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...

Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...

An OU Health eye specialist explains who is most at risk, why symptoms are rare, and how early exams can prevent permanent blindness.

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...

A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...

Artificial intelligence is radically changing how healthcare providers tackle vision loss, with tools that can be used from diagnosis to treatment and even follow-up care. One such example is Visilant ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple sclerosis.

Researchers estimate that about 1.8 billion people around the world live with presbyopia, a farsightedness condition that can appear as a person grows older. More recent treatment options for ...

January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and ...

Weight-loss drugs may cause serious eye diseases leading to vision loss in some people, two new studies suggest. One study, published in JAMA, assessed data from nearly 1.5 million people and found ...